Director, Nonclinical Due Diligence & External Innovation

ppThe Director Non-Clinical Due Diligence External Evaluations provides scientific leadership for nonclinical due diligence supporting CSL’s in‑licensing, acquisitions, and strategic collaborations. The role ensures integrated, objective, and decision‑relevant evaluations of nonclinical pharmacology, PK/QSP, and toxicology data to identify development risks, data gaps, and mitigation strategies and to inform portfolio decisions. /p pThe incumbent will further act as nonclinical representative for selected Research programs and support oversight of nonclinical strategies and programs across all Therapeutic Areas. /p pThe role reports to the Executive Director, Head of Nonclinical Development. /p h3Responsibilities and accountabilities /h3 ul liLeads operational execution of nonclinical due diligence for assigned opportunities. /li liActs as hands‑on scientific integrator, translating expert input into clear risk narratives. /li liTrusted subject‑matter lead for nonclinical DD on individual deals. /li liLead end-to-end nonclinical due diligence for individual assets or transactions, from request through final governance readout. /li liIntegrate input from Toxicology, PK/QSP, Nonclinical Pharmacology, and external experts into a single, coherent scientific assessment. /li liIdentify FIH‑enabling gaps, translational risks, and regulatory limitations, with clear mitigation proposals. /li liPrepare high‑quality DD reports, executive summaries, and risk tables for governance review. /li liAct as NCD scientific interface to Business Development and Therapeutic Area teams at the project level. /li liContribute to maintenance and continuous improvement of nonclinical DD frameworks and templates. /li liMentor junior contributors and matrix team members as appropriate. /li liEscalates complex or high‑impact issues to Head of NCD /li liChair of “NCD Review Committee” /li /ul h3Qualifications: /h3 h3Education: /h3 ul liAdvanced degree (Ph.D., D.V.M., or equivalent) in toxicology, pharmacology, or a related field /li liToxicology training, board certification preferred /li /ul h3Experience : /h3 ul liExperience in nonclinical development (10+ years) with proven experience in due diligence or external innovation, ideally across various geographies. /li liStrong understanding of FIH‑enabling nonclinical requirements, particularly for biologics and complex modalities. /li liAbility to communicate complex scientific risk clearly to non‑expert stakeholders. /li liExperience across multiple therapeutic areas and modalities is highly desirable. /li liProven ability to work effectively both independently or in a team setting, and to meet set goals by managing own timelines. /li liExperience in working in cross-functional, multicultural and international teams. /li liExcellent communication and analytical skills. /li liExperience in analyzing and presenting research results to scientific and professional audiences. /li liStrong planning and organizational skills. /li liAbility to work successfully in a matrix organizational structure. /li liStrong negotiation skills and ability to identify and engage internal and external expertise as needed. /li liGood understanding of drug development process, strong knowledge of ICH/GLP /li liFluent in English, oral and written; /li /ul pThe role requires onsite presence 3 days per week. /p pThe role can be based in Zurich, Switzerland or Waltham, USA. /p /p #J-18808-Ljbffr